Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7B51

Crystal structure of human CRM1 covalently modified by 2-mercaptoethanol at Cys528

7B51 の概要
エントリーDOI10.2210/pdb7b51/pdb
分子名称GTP-binding nuclear protein Ran, Exportin-1, GUANOSINE-5'-TRIPHOSPHATE, ... (6 entities in total)
機能のキーワードexportin, inhibition, nuclear protein
由来する生物種Homo sapiens (Human)
詳細
タンパク質・核酸の鎖数2
化学式量合計143374.38
構造登録者
Shaikhqasem, A.,Ficner, R. (登録日: 2020-12-03, 公開日: 2021-03-10, 最終更新日: 2024-01-31)
主引用文献Shaikhqasem, A.,Schmitt, K.,Valerius, O.,Ficner, R.
Crystal structure of human CRM1, covalently modified by 2-mercaptoethanol on Cys528, in complex with RanGTP.
Acta Crystallogr.,Sect.F, 77:70-78, 2021
Cited by
PubMed Abstract: CRM1 is a nuclear export receptor that has been intensively targeted over the last decade for the development of antitumor and antiviral drugs. Structural analysis of several inhibitor compounds bound to CRM1 revealed that their mechanism of action relies on the covalent modification of a critical cysteine residue (Cys528 in the human receptor) located in the nuclear export signal-binding cleft. This study presents the crystal structure of human CRM1, covalently modified by 2-mercaptoethanol on Cys528, in complex with RanGTP at 2.58 Å resolution. The results demonstrate that buffer components can interfere with the characterization of cysteine-dependent inhibitor compounds.
PubMed: 33682791
DOI: 10.1107/S2053230X2100203X
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.58 Å)
構造検証レポート
Validation report summary of 7b51
検証レポート(詳細版)ダウンロードをダウンロード

237423

件を2025-06-11に公開中

PDB statisticsPDBj update infoContact PDBjnumon